M&A Deal Summary

Edwards Acquires Harpoon Medical

On December 6, 2017, Edwards acquired medical products company Harpoon Medical for 100M USD

Acquisition Highlights
  • This is Edwards’ 9th transaction in the Medical Products sector.
  • This is Edwards’ 5th largest (disclosed) transaction.
  • This is Edwards’ 8th transaction in the United States.
  • This is Edwards’ 1st transaction in Maryland.

M&A Deal Summary
Date 2017-12-06
Target Harpoon Medical
Sector Medical Products
Buyer(s) Edwards
Deal Type Add-on Acquisition
Deal Value 100M USD

Target

Harpoon Medical

Baltimore, Maryland, United States
Harpoon Medical, Inc. is a medical technology company pioneering beating-heart repair for degenerative mitral regurgitation (DMR). Harpoon Medical is based in Baltimore, Maryland.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Edwards

Irvine, California, United States
Category Company
Founded 1958
Sector Medical Products
Employees19,800
Revenue 6.0B USD (2023)
DESCRIPTION
Entrance to Edwards Lifesciences' corporate headquarters in Irvine, California.
Entrance to Edwards Lifesciences' corporate headquarters in Irvine, California.

Edwards is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. Edwards was founded in 1958 and is based in Irvine, California.

DEAL STATS #
Overall 12 of 15
Sector (Medical Products) 9 of 12
Type (Add-on Acquisition) 6 of 9
State (Maryland) 1 of 1
Country (United States) 8 of 11
Year (2017) 1 of 1
Size (of disclosed) 5 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-28 Valtech Cardio

Yehuda, Israel

Valtech Cardio Ltd. is specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases – mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR).

Buy $340M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-12 CAS Medical Systems

Branford, Connecticut, United States

CAS Medical Systems, Inc. is a designer, manufacturer, and marketer of FORE-SIGHT Tissue Oximetry., CAS Medical Systems was founded in 1984 and is based in Branford, Connecticut.

Buy $100M
Mergr

Product

Company

Legal